Atrial Fibrillation (AF) stands as a common cardiac rhythm disorder marked by irregular and frequently accelerated heartbeats. This condition arises when the heart's upper chambers (atria) undergo a quivering or fluttering motion, disrupting the normal electrical impulses that coordinate heartbeats. Consequently, the heart may struggle to efficiently pump blood, potentially leading to complications like blood clots, strokes, or heart failure. Although AF can affect individuals of various age groups, its prevalence tends to increase with age, with factors such as hypertension, diabetes, and heart disease heightening the risk. Recognizable symptoms encompass palpitations, fatigue, dizziness, and shortness of breath. The timely identification and effective management of Atrial Fibrillation are pivotal in reducing associated risks and improving the quality of life for those impacted. Treatment approaches typically include medications, lifestyle adjustments, and, in specific cases, medical procedures designed to restore or regulate the heart's rhythm. Ongoing research efforts contribute to a growing understanding of AF mechanisms, offering promise for innovative treatment options and advancements in patient care.
Title : Investigating the long-term follow up of atrial septal device closures in wales and england: A comparative analysis with major adverse cardiovascular Events (MACE)
Meera Gopinath, Cardiff University Medical school, United Kingdom
Title : An adult case of polysplenia syndrome associated with sinus node dysfunction
Apoorva Tripathi, Oxford University Hospitals, United Kingdom
Title : A unique cell-driven phenomenon in the heart and the promising future of the innovative translational tools to manage cardiac self-renewal and regeneration
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Personalized and precision medicine (PPM) as a unique healthcare model through biodesign-driven translational applications and cardiology-related healthcare marketing to secure the human healthcare and biosafety
Sergey Suchkov, N. D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences, Russian Federation
Title : Yasser’s criterion of inferior ST-segment discrepancy deviations in AF with aberrancy and Sgarbosa criteria - a new cardiovascular discovery and management - a case report
Yasser Mohammed Hassanain Elsayed, Egyptian Ministry of Health, Egypt